These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11892720)

  • 21. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine augmentation in the treatment of refractory depression.
    Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
    J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study.
    Schüle C; Zwanzger P; Baghai T; Mikhaiel P; Thoma H; Möller HJ; Rupprecht R; Padberg F
    J Psychiatr Res; 2003; 37(2):145-53. PubMed ID: 12842168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nortriptyline on heart rate variability in panic disorder patients: a preliminary study using power spectral analysis of heart rate.
    Yeragani VK; Srinivasan K; Pohl R; Berger R; Balon R; Ramesh C
    Neuropsychobiology; 1994; 29(1):1-7. PubMed ID: 8127417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study.
    Montgomery SA; Reimitz PE; Zivkov M
    Int Clin Psychopharmacol; 1998 Mar; 13(2):63-73. PubMed ID: 9669186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers.
    Slaap BR; Nielen MM; Boshuisen ML; van Roon AM; den Boer JA
    J Affect Disord; 2004 Feb; 78(2):141-8. PubMed ID: 14706724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-injury related phobic avoidance as predictor of nonresponse to pharmacotherapy in panic disorder with agoraphobia.
    Overbeek T; Büchold H; Schruers K; Griez E
    J Affect Disord; 2004 Mar; 78(3):227-33. PubMed ID: 15013247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O; Szegedi A; Philipp M; Kohnen R; Heinrich C; Heukels A; van der Vegte-Senden M; Baker RA; Simmons JH; Schutte AJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-generation antipsychotics combination trial.
    Terevnikov V; Stenberg JH; Tiihonen J; Chukhin E; Joffe M; Burkin M; Joffe G
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1661-6. PubMed ID: 23217660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke.
    Niedermaier N; Bohrer E; Schulte K; Schlattmann P; Heuser I
    J Clin Psychiatry; 2004 Dec; 65(12):1619-23. PubMed ID: 15641866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.